List of Tables
Table 1. Global Drugs for Sexual Dysfunction Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Drugs for Sexual Dysfunction Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Drugs for Sexual Dysfunction Market Competitive Situation by Manufacturers in 2025
Table 4. Global Drugs for Sexual Dysfunction Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Drugs for Sexual Dysfunction Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Drugs for Sexual Dysfunction Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Drugs for Sexual Dysfunction Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Drugs for Sexual Dysfunction Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Drugs for Sexual Dysfunction, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Drugs for Sexual Dysfunction, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Drugs for Sexual Dysfunction, Product Types and Applications
Table 12. Global Key Manufacturers of Drugs for Sexual Dysfunction, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drugs for Sexual Dysfunction Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drugs for Sexual Dysfunction Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs for Sexual Dysfunction Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Drugs for Sexual Dysfunction Sales by Region (K Units), 2021–2026
Table 18. Global Drugs for Sexual Dysfunction Sales Market Share by Region (2021–2026)
Table 19. Global Drugs for Sexual Dysfunction Sales by Region (K Units), 2027–2032
Table 20. Global Drugs for Sexual Dysfunction Sales Market Share by Region (2027–2032)
Table 21. Global Drugs for Sexual Dysfunction Revenue by Region (US$ Million), 2021–2026
Table 22. Global Drugs for Sexual Dysfunction Revenue Market Share by Region (2021–2026)
Table 23. Global Drugs for Sexual Dysfunction Revenue by Region (US$ Million), 2027–2032
Table 24. Global Drugs for Sexual Dysfunction Revenue Market Share by Region (2027–2032)
Table 25. North America Drugs for Sexual Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Drugs for Sexual Dysfunction Sales by Country (K Units), 2021–2026
Table 27. North America Drugs for Sexual Dysfunction Sales by Country (K Units), 2027–2032
Table 28. North America Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2021–2026
Table 29. North America Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Drugs for Sexual Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Drugs for Sexual Dysfunction Sales by Country (K Units), 2021–2026
Table 32. Europe Drugs for Sexual Dysfunction Sales by Country (K Units), 2027–2032
Table 33. Europe Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Drugs for Sexual Dysfunction Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Drugs for Sexual Dysfunction Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Drugs for Sexual Dysfunction Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Drugs for Sexual Dysfunction Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Drugs for Sexual Dysfunction Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Drugs for Sexual Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Drugs for Sexual Dysfunction Sales by Country (K Units), 2021–2026
Table 42. Latin America Drugs for Sexual Dysfunction Sales by Country (K Units), 2027–2032
Table 43. Latin America Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Drugs for Sexual Dysfunction Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Drugs for Sexual Dysfunction Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Drugs for Sexual Dysfunction Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Drugs for Sexual Dysfunction Revenue by Country (US$ Million), 2027–2032
Table 50. Global Drugs for Sexual Dysfunction Sales (K Units) by Type (2021–2026)
Table 51. Global Drugs for Sexual Dysfunction Sales (K Units) by Type (2027–2032)
Table 52. Global Drugs for Sexual Dysfunction Sales Market Share by Type (2021–2026)
Table 53. Global Drugs for Sexual Dysfunction Sales Market Share by Type (2027–2032)
Table 54. Global Drugs for Sexual Dysfunction Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Drugs for Sexual Dysfunction Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Drugs for Sexual Dysfunction Revenue Market Share by Type (2021–2026)
Table 57. Global Drugs for Sexual Dysfunction Revenue Market Share by Type (2027–2032)
Table 58. Global Drugs for Sexual Dysfunction Price (US$/Unit) by Type (2021–2026)
Table 59. Global Drugs for Sexual Dysfunction Price (US$/Unit) by Type (2027–2032)
Table 60. Global Drugs for Sexual Dysfunction Sales (K Units) by Application (2021–2026)
Table 61. Global Drugs for Sexual Dysfunction Sales (K Units) by Application (2027–2032)
Table 62. Global Drugs for Sexual Dysfunction Sales Market Share by Application (2021–2026)
Table 63. Global Drugs for Sexual Dysfunction Sales Market Share by Application (2027–2032)
Table 64. Global Drugs for Sexual Dysfunction Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Drugs for Sexual Dysfunction Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Drugs for Sexual Dysfunction Revenue Market Share by Application (2021–2026)
Table 67. Global Drugs for Sexual Dysfunction Revenue Market Share by Application (2027–2032)
Table 68. Global Drugs for Sexual Dysfunction Price (US$/Unit) by Application (2021–2026)
Table 69. Global Drugs for Sexual Dysfunction Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Inc Company Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Inc Drugs for Sexual Dysfunction Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. Bayer AG Company Information
Table 76. Bayer AG Description and Business Overview
Table 77. Bayer AG Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bayer AG Drugs for Sexual Dysfunction Product
Table 79. Bayer AG Recent Developments/Updates
Table 80. Boston Scientific Corporation Company Information
Table 81. Boston Scientific Corporation Description and Business Overview
Table 82. Boston Scientific Corporation Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Boston Scientific Corporation Drugs for Sexual Dysfunction Product
Table 84. Boston Scientific Corporation Recent Developments/Updates
Table 85. SK Chemicals. Company Information
Table 86. SK Chemicals. Description and Business Overview
Table 87. SK Chemicals. Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. SK Chemicals. Drugs for Sexual Dysfunction Product
Table 89. SK Chemicals. Recent Developments/Updates
Table 90. Teva Pharmaceutical Industries Ltd. Company Information
Table 91. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 92. Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Teva Pharmaceutical Industries Ltd. Drugs for Sexual Dysfunction Product
Table 94. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 95. Meda Pharmaceuticals Company Information
Table 96. Meda Pharmaceuticals Description and Business Overview
Table 97. Meda Pharmaceuticals Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Meda Pharmaceuticals Drugs for Sexual Dysfunction Product
Table 99. Meda Pharmaceuticals Recent Developments/Updates
Table 100. Sanofi Company Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Sanofi Drugs for Sexual Dysfunction Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Lilly Company Information
Table 106. Lilly Description and Business Overview
Table 107. Lilly Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Lilly Drugs for Sexual Dysfunction Product
Table 109. Lilly Recent Developments/Updates
Table 110. Menarini Group Company Information
Table 111. Menarini Group Description and Business Overview
Table 112. Menarini Group Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Menarini Group Drugs for Sexual Dysfunction Product
Table 114. Menarini Group Recent Developments/Updates
Table 115. Vivus, Inc. Company Information
Table 116. Vivus, Inc. Description and Business Overview
Table 117. Vivus, Inc. Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Vivus, Inc. Drugs for Sexual Dysfunction Product
Table 119. Vivus, Inc. Recent Developments/Updates
Table 120. Lilly ICOS LLC Company Information
Table 121. Lilly ICOS LLC Description and Business Overview
Table 122. Lilly ICOS LLC Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Lilly ICOS LLC Drugs for Sexual Dysfunction Product
Table 124. Lilly ICOS LLC Recent Developments/Updates
Table 125. Hims Company Information
Table 126. Hims Description and Business Overview
Table 127. Hims Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Hims Drugs for Sexual Dysfunction Product
Table 129. Hims Recent Developments/Updates
Table 130. Lupin Company Information
Table 131. Lupin Description and Business Overview
Table 132. Lupin Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Lupin Drugs for Sexual Dysfunction Product
Table 134. Lupin Recent Developments/Updates
Table 135. CSBio Company Information
Table 136. CSBio Description and Business Overview
Table 137. CSBio Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. CSBio Drugs for Sexual Dysfunction Product
Table 139. CSBio Recent Developments/Updates
Table 140. General Factory Company Information
Table 141. General Factory Description and Business Overview
Table 142. General Factory Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. General Factory Drugs for Sexual Dysfunction Product
Table 144. General Factory Recent Developments/Updates
Table 145. Dong-A ST Company Information
Table 146. Dong-A ST Description and Business Overview
Table 147. Dong-A ST Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Dong-A ST Drugs for Sexual Dysfunction Product
Table 149. Dong-A ST Recent Developments/Updates
Table 150. Metuchen Pharma Company Information
Table 151. Metuchen Pharma Description and Business Overview
Table 152. Metuchen Pharma Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Metuchen Pharma Drugs for Sexual Dysfunction Product
Table 154. Metuchen Pharma Recent Developments/Updates
Table 155. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Company Information
Table 156. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Description and Business Overview
Table 157. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Drugs for Sexual Dysfunction Product
Table 159. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Drugs for Sexual Dysfunction Distributors List
Table 163. Drugs for Sexual Dysfunction Customers List
Table 164. Drugs for Sexual Dysfunction Market Trends
Table 165. Drugs for Sexual Dysfunction Market Drivers
Table 166. Drugs for Sexual Dysfunction Market Challenges
Table 167. Drugs for Sexual Dysfunction Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drugs for Sexual Dysfunction
Figure 2. Global Drugs for Sexual Dysfunction Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Drugs for Sexual Dysfunction Market Share by Type: 2025 & 2032
Figure 4. Sildenafil (Viagra) Product Picture
Figure 5. Vardenafil (Levitra, Staxyn) Product Picture
Figure 6. Tadalafil (Cialis) Product Picture
Figure 7. Udenafil (Zydena) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Drugs for Sexual Dysfunction Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Drugs for Sexual Dysfunction Market Share by Application: 2025 & 2032
Figure 11. Hospitals
Figure 12. Retail Pharmacies
Figure 13. Clinics
Figure 14. Online Pharmacies
Figure 15. Global Drugs for Sexual Dysfunction Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Drugs for Sexual Dysfunction Market Size (US$ Million), 2021–2032
Figure 17. Global Drugs for Sexual Dysfunction Sales (K Units), 2021–2032
Figure 18. Global Drugs for Sexual Dysfunction Average Price (US$/Unit), 2021–2032
Figure 19. Drugs for Sexual Dysfunction Report Years Considered
Figure 20. Drugs for Sexual Dysfunction Sales Share by Manufacturers in 2025
Figure 21. Global Drugs for Sexual Dysfunction Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Drugs for Sexual Dysfunction Players: Market Share by Revenue in Drugs for Sexual Dysfunction in 2025
Figure 23. Drugs for Sexual Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Drugs for Sexual Dysfunction Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Drugs for Sexual Dysfunction Sales Market Share by Country (2021–2032)
Figure 26. North America Drugs for Sexual Dysfunction Revenue Market Share by Country (2021–2032)
Figure 27. United States Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Drugs for Sexual Dysfunction Sales Market Share by Country (2021–2032)
Figure 30. Europe Drugs for Sexual Dysfunction Revenue Market Share by Country (2021–2032)
Figure 31. Germany Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Drugs for Sexual Dysfunction Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Drugs for Sexual Dysfunction Revenue Market Share by Region (2021–2032)
Figure 38. China Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Drugs for Sexual Dysfunction Sales Market Share by Country (2021–2032)
Figure 46. Latin America Drugs for Sexual Dysfunction Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Drugs for Sexual Dysfunction Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Drugs for Sexual Dysfunction Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Drugs for Sexual Dysfunction Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Drugs for Sexual Dysfunction by Type (2021–2032)
Figure 57. Global Revenue Market Share of Drugs for Sexual Dysfunction by Type (2021–2032)
Figure 58. Global Drugs for Sexual Dysfunction Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Drugs for Sexual Dysfunction by Application (2021–2032)
Figure 60. Global Revenue Market Share of Drugs for Sexual Dysfunction by Application (2021–2032)
Figure 61. Global Drugs for Sexual Dysfunction Price (US$/Unit) by Application (2021–2032)
Figure 62. Drugs for Sexual Dysfunction Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
